Skip to main content

Incyte JAKAFI revenue

  • INCY · Nasdaq
  • Biotechnology
  • S&P 500
$120.97−0.60%Close 13 Nov 2026 · Market value $24.66B

JAKAFI revenue at Incyte came to $826.5M for the quarter to 30 Sep 2026, up 4.5% from a year earlier.

As Incyte reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Oct 2026.

By quarter

$695.1MDec 2023$571.8MMar 2024$706.0MJun 2024$741.2MSep 2024$773.1MDec 2024$709.4MMar 2025$763.8MJun 2025$791.1MSep 2025$828.2MDec 2025$757.8MMar 2026$816.7MJun 2026$826.5MSep 2026
Incyte JAKAFI revenue, every reported period
Period endingJAKAFI revenueChange on a yearFiled
30 Sep 2026$826.5Mup 4.5%29 Oct 2026
30 Jun 2026$816.7Mup 6.9%28 Jul 2026
31 Mar 2026$757.8Mup 6.8%28 Apr 2026
31 Dec 2025$828.2Mup 7.1%10 Feb 2026
30 Sep 2025$791.1Mup 6.7%28 Oct 2025
30 Jun 2025$763.8Mup 8.2%29 Jul 2025
31 Mar 2025$709.4Mup 24.1%29 Apr 2025
31 Dec 2024$773.1Mup 11.2%10 Feb 2025
30 Sep 2024$741.2Mup 16.5%29 Oct 2024
30 Jun 2024$706.0Mup 3.5%30 Jul 2024
31 Mar 2024$571.8Mdown 1.4%30 Apr 2024
31 Dec 2023$695.1Mup 7.4%13 Feb 2024
30 Sep 2023$636.3Mup 2.7%31 Oct 2023
30 Jun 2023$682.4Mup 14.2%1 Aug 2023
31 Mar 2023$580.0Mup 6.5%2 May 2023
31 Dec 2022$647.5Mup 9.3%7 Feb 2023
30 Sep 2022$619.6Mup 13.2%1 Nov 2022
30 Jun 2022$597.7Mup 13.0%2 Aug 2022
31 Mar 2022$544.5Mup 16.9%3 May 2022
31 Dec 2021$592.4Mup 14.6%8 Feb 2022
30 Sep 2021$547.4Mup 12.2%2 Nov 2021
30 Jun 2021$529.1Mup 11.7%3 Aug 2021
31 Mar 2021$465.7Mup 1.4%4 May 2021
31 Dec 2020$516.9Mup 10.8%9 Feb 2021
30 Sep 2020$487.8Mup 12.6%5 Nov 2020
30 Jun 2020$473.7Mup 15.7%4 Aug 2020
31 Mar 2020$459.5Mup 22.3%5 May 2020
31 Dec 2019$466.5Mup 22.7%13 Feb 2020
30 Sep 2019$433.4Mup 24.7%29 Oct 2019
30 Jun 2019$409.5Mup 18.5%30 Jul 2019
31 Mar 2019$375.6Mup 19.7%30 Apr 2019
31 Dec 2018$380.1M—14 Feb 2019
30 Sep 2018$347.6M—30 Oct 2018
30 Jun 2018$345.6M—31 Jul 2018
31 Mar 2018$313.7M—1 May 2018

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Incyte: Customer A (change on a year) · Customer B (change on a year) · Customer C (change on a year) · OPZELURA revenue · Product royalty revenues · JAKAVI revenue · NIKTIMVO revenue · ZYNYZ revenue · MINJUVI/MONJUVI revenue · Milestone and contract revenues · OLUMIANT revenue · ICLUSIG revenue · PEMAZYRE revenue · TABRECTA revenue · United States revenue · Europe revenue · financial statements

Every KPI and segment of INCY, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.